Membrane Anchor of Cytochrome P450 Reductase Suppresses the Uncoupling of Cytochrome P450
Open Access
- 1 January 2015
- journal article
- research article
- Published by Pharmaceutical Society of Japan in Chemical and Pharmaceutical Bulletin
- Vol. 63 (4) , 286-294
Abstract
Cytochrome P450 reductase (CPR) is an important redox partner of microsomal CYPs. CPR is composed of a membrane anchor and a catalytic domain that contains FAD and flavin mononucleotide (FMN) as redox centers and mediates electron transfer to CYP. Although the CPR membrane anchor is believed to be requisite for interaction with CYP, its physiological role is still controversial. To clarify the role of the anchor, we constructed a mutant (Δ60-CPR) in which the N-terminal membrane anchor was truncated, and studied its effect on binding properties, electron transfer to CYP2C19, and drug metabolism. We found that Δ60-CPR could bind to and transfer electrons to CYP2C19 as efficiently as WT-CPR, even in the absence of lipid membrane. In accordance with this, Δ60-CPR could mediate metabolism of amitriptyline (AMT) and imipramine (IMP) in the absence of lipids, although activity was diminished. However, Δ60-CPR failed to metabolize omeprazole (OPZ) and lansoprazole (LPZ). To clarify the reason for this discrepancy in drug metabolism, we investigated the uncoupling reaction of the CYP catalytic cycle. By measuring the amount of H2O2 by-product, we found that shunt pathways were markedly activated in the presence of OPZ/LPZ in the Δ60-CPR mutant. Because H2O2 levels varied among the drugs, we conclude that the proton network in the distal pocket of CYP2C19 is perturbed differently by different drugs, and activated oxygen is degraded to become H2O2. Therefore, we propose a novel role for the membrane anchor as a suppressor of the uncoupling reaction in drug metabolism by CYP.Keywords
This publication has 53 references indexed in Scilit:
- Redox-Linked Domain Movements in the Catalytic Cycle of Cytochrome P450 ReductaseStructure, 2013
- Structural basis for human NADPH-cytochrome P450 oxidoreductase deficiencyProceedings of the National Academy of Sciences, 2011
- Conformational Changes of NADPH-Cytochrome P450 Oxidoreductase Are Essential for Catalysis and Cofactor BindingJournal of Biological Chemistry, 2011
- Domain Motion in Cytochrome P450 ReductaseJournal of Biological Chemistry, 2009
- Modulation of the Cytochrome P450 Reductase Redox Potential by the Phospholipid BilayerBiochemistry, 2009
- Structure and Function of an NADPH-Cytochrome P450 Oxidoreductase in an Open Conformation Capable of Reducing Cytochrome P450Journal of Biological Chemistry, 2009
- Polymorphic Variants of CYP2C9: Mechanisms Involved in Reduced Catalytic ActivityMolecular Pharmacology, 2007
- Activities and Kinetic Mechanisms of Native and Soluble NADPH–Cytochrome P450 ReductaseBiochemical and Biophysical Research Communications, 2001
- Role of a hydrophobic polypeptide in the N-terminal region of NADPH-cytochrome P-450 reductase in complex formation with P-450lmBiochemical and Biophysical Research Communications, 1979
- Phospholipids and detergents as effectors in the liver microsomal hydroxylase systemBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977